Comment

CDISC recommends Serious Adverse Event promotion in v5

CDISC recommends the data element "Serious Adverse Event" be considered for promotion in USCDI v5.  

The rationale is that it will aid in drug safety, patient safety and clinical research. HL7 Vulcan Adverse Event working group is close to publishing two implementation guides to clarify how the data element would be used: 
http://hl7.org/fhir/uv/ae-research-ig/2023Sep/StructureDefinition-AdverseEvent-clinical-research.html
https://build.fhir.org/ig/HL7/fhir-ae-research-backport-ig/index.html

The FHIR AdverseEvent Resource is Maturity Level 2
http://build.fhir.org/adverseevent.html
 

Thank you for the opportunity to comment.

test

test

Log in or register to post comments